Skip to content

Clinical trials

Phase 3 Dyslipidemias trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 3 Status: Unknown status Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20171
20182
20192
20213
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Daewoong Pharmaceutical Co. LTD.2
Chong Kun Dang Pharmaceutical1
EMS1
Hospital Civil de Guadalajara1
Instituto de Cardiologia do Rio Grande do Sul1
King Saud University1
Laboratorios Grossman, S.A.1
Laboratorios Silanes S.A. de C.V.1
Mansoura University1
Torrent Pharmaceuticals Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias12
Hypertension3
Diabetes Mellitus, Type 22
Diabetes Mellitus1
Glucose Intolerance1
Hypertriglyceridemia1
Inflammation1
Lipodystrophy1
Metabolic Syndrome1
Obesity1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.